Viewing Study NCT03312335


Ignite Creation Date: 2025-12-24 @ 10:10 PM
Ignite Modification Date: 2026-01-04 @ 4:20 PM
Study NCT ID: NCT03312335
Status: COMPLETED
Last Update Posted: 2020-08-19
First Post: 2017-09-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Low-dose Interleukin-2 for Treatment of Systemic Lupus Erythematosus
Sponsor: Onur Boyman, MD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module